Last reviewed · How we verify

NCT04688957

Osseodensification by Densah Burs Versus Osteotome

Status unknown NA Last updated 30 December 2020
What this trial tests

NA trial testing oseodensification sinus lifting in Maxillary Sinus Lift in 12 participants. Status unknown.

Timeline
12 December 2020
Primary endpoint
1 July 2021
1 August 2021

Quick facts

Lead sponsorHams Hamed Abdelrahman
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment12
Start date12 December 2020
Primary completion1 July 2021
Estimated completion1 August 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Hams Hamed Abdelrahman — full company profile →

Who can join

Adults 20 to 50, any sex, with Maxillary Sinus Lift. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

implant placement in the posterior maxilla is problematic, not only due to inferior properties of bone but also due to loss of vertical bone height which happens after extraction of posterior teeth. when the required additional height is few millimeters, indirect transcresta sinus lifting procedures are recommended. This study compares sinus lifting using the conventional osteotome versus the osseodensification with densah burs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Radiographic comparison between Densah burs and osteotome for graftless internal sinus lifting with simultaneous implant placement: a randomized clinical trial.
    Elghobashy MTM, Shaaban AM, Melek LNF. · · 2023 · cited 5× · PMID 35840446 · DOI 10.1016/j.ijom.2022.06.020

Verify or expand the search:

Other Hams Hamed Abdelrahman trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04688957.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing